Health Canada is stopping the sale of thioridazine

Health Canada is stopping the sale of thioridazine.

There's not enough proof that it's safe. There are reports of thioridazine causing prolonged QT interval and sudden death.

Manufacturers will not sell it after Sep 30th...but you can still dispense it until patients are switched to an alternative.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote